|
DEVELOPING ALTERNATIVE APPROACHES TO REDUCE RETINAL TOXICITY AND PREVENT VISION LOSS IN THE TREATMENT OF INTRAOCULAR RETINOBLASTOMA |
1K08EY027464-01 |
DANIELS, ANTHONY BRENT |
NEI |
2017 |
|
PATHOGENIC B CELL AND T HELPER CELL INTERACTIONS IN NEUROMYELITIS OPTICA |
1R01EY027346-01 |
AXTELL, ROBERT C |
NEI |
2017 |
|
INCIDENCE OF REMISSION AND OF CATARACT IN OCULAR INFLAMMATORY DISEASES |
1R21EY026717-01A1 |
KEMPEN, JOHN H |
NEI |
2017 |
|
RISK FACTOR ANAYLYSIS OF PERIOPERATIVE VISUAL LOSS |
1R21EY027447-01A1 |
ROTH, STEVEN |
NEI |
2017 |
|
RETINAL CIRCUIT DEVELOPMENT & GENETICS |
1ZIAEY000504-07 |
BADEA, TUDOR |
NEI |
2017 |
|
STUDIES OF OCULAR INFLAMMATION: CLINICAL RESEARCH |
1ZIAEY000557-01 |
SEN, HATICE |
NEI |
2017 |
|
AQUAPORIN-4 IN NMO OPTIC NEURITIS: PATHOGENESIS AND NEW THERAPIES |
5R01EY013574-15 |
VERKMAN, ALAN S |
NEI |
2017 |
|
COGNITIVE NEURAL PROSTHETICS FOR CLINICAL APPLICATIONS |
5R01EY015545-12 |
ANDERSEN, RICHARD A |
NEI |
2017 |
|
MECHANISM OF SIRT1 ACTIVATOR MEDIATED NEUROPROTECTION OF RETINAL GANGLION CELLS |
5R01EY019014-07 |
SHINDLER, KENNETH S |
NEI |
2017 |
|
HUMORAL IMMUNITY, ASTROCYTE INJURY, AND DEMYELINATION IN NEUROMYELITIS OPTICA |
5R01EY022936-05 |
BENNETT, JEFFREY L |
NEI |
2017 |